Most Recent Articles by Diana Ernst
The approval was based on data from the Td537 study which included individuals 18-64 years old who had received a dose of Adacel 8-12 years prior (N=1330).
According to the Company, a Phase 1 placebo-controlled, dose-escalation study of BXCL501 is expected to enroll up to 60 healthy adults across various dosing groups; pharmacokinetics and safety will be evaluated as primary endpoints.
Reports of serious adverse events related to dietary supplements containing the unapproved opioid-like antidepressant tianeptine have prompted FDA warnings.
Pimodivir was found to be beneficial in the treatment of acute uncomplicated influenza A virus infection in adult patients.
The FDA has approved the use of Oralair for the treatment of grass pollen-induced allergic rhinitis in pediatric patients aged 5-9.